A detailed history of American Century Companies Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, American Century Companies Inc holds 3,346,693 shares of ABBV stock, worth $602 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
3,346,693
Previous 2,897,649 15.5%
Holding current value
$602 Million
Previous $497 Million 32.98%
% of portfolio
0.4%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $73.6 Million - $89.5 Million
449,044 Added 15.5%
3,346,693 $661 Million
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $36.4 Million - $42.5 Million
235,348 Added 8.84%
2,897,649 $497 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $14 Million - $15.9 Million
87,521 Added 3.4%
2,662,301 $485 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $354 Million - $399 Million
2,574,780 New
2,574,780 $399 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $20.1 Million - $23.2 Million
-150,099 Reduced 5.67%
2,496,495 $372 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $17.7 Million - $22 Million
-133,213 Reduced 4.79%
2,646,594 $357 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $15.3 Million - $17.6 Million
-105,561 Reduced 3.66%
2,779,807 $443 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $16.4 Million - $19.6 Million
-118,235 Reduced 3.94%
2,885,368 $467 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $12.7 Million - $14.5 Million
94,515 Added 3.25%
3,003,603 $403 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $251 Million - $319 Million
1,822,685 Added 167.77%
2,909,088 $446 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $48.7 Million - $60.4 Million
-368,824 Reduced 25.34%
1,086,403 $176 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $46.4 Million - $58.7 Million
431,652 Added 42.17%
1,455,227 $197 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $49.1 Million - $55.8 Million
-461,798 Reduced 31.09%
1,023,575 $110 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $14.9 Million - $16.6 Million
141,876 Added 10.56%
1,485,373 $167 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $27.5 Million - $30.3 Million
268,906 Added 25.02%
1,343,497 $145 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $5.23 Million - $7.06 Million
64,999 Added 6.44%
1,074,591 $115 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $15.2 Million - $17.8 Million
176,816 Added 21.23%
1,009,592 $88.4 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $43.4 Million - $58.1 Million
-592,171 Reduced 41.56%
832,776 $81.8 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $41.6 Million - $63 Million
644,483 Added 82.58%
1,424,947 $109 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $18.2 Million - $22.8 Million
-252,857 Reduced 24.47%
780,464 $69.1 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $14.9 Million - $17.9 Million
-236,701 Reduced 18.64%
1,033,321 $78.2 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $21.3 Million - $27.3 Million
-324,579 Reduced 20.35%
1,270,022 $92.4 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $14.6 Million - $17.1 Million
-188,840 Reduced 10.59%
1,594,601 $0
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $10.1 Million - $12.5 Million
130,043 Added 7.87%
1,783,441 $164 Million
Q3 2018

Nov 02, 2018

SELL
$88.91 - $98.84 $8.33 Million - $9.26 Million
-93,674 Reduced 5.36%
1,653,398 $156 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $9.89 Million - $11.7 Million
-110,145 Reduced 5.93%
1,747,072 $162 Million
Q1 2018

May 03, 2018

SELL
$92.01 - $123.21 $12.3 Million - $16.5 Million
-133,884 Reduced 6.72%
1,857,217 $176 Million
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $14.2 Million - $15.5 Million
-158,188 Reduced 7.36%
1,991,101 $193 Million
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $150 Million - $192 Million
2,149,289
2,149,289 $191 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.